Literature DB >> 21733699

Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.

Elizabeth I Parkinson1, M Jason Hatfield, Lyudmila Tsurkan, Janice L Hyatt, Carol C Edwards, Latorya D Hicks, Bing Yan, Philip M Potter.   

Abstract

Carboxylesterases (CE) are ubiquitous enzymes found in both human and animal tissues and are responsible for the metabolism of xenobiotics. This includes numerous natural products, as well as a many clinically used drugs. Hence, the activity of these agents is likely dependent upon the levels and location of CE expression. We have recently identified benzil is a potent inhibitor of mammalian CEs, and in this study, we have assessed the ability of analogues of this compound to inhibit these enzymes. Three different classes of molecules were assayed: one containing different atoms vicinal to the carbonyl carbon atom and the benzene ring [PhXC(O)C(O)XPh, where X=CH₂, CHBr, N, S, or O]; a second containing a panel of alkyl 1,2-diones demonstrating increasing alkyl chain length; and a third consisting of a series of 1-phenyl-2-alkyl-1,2-diones. In general, with the former series of molecules, heteroatoms resulted in either loss of inhibitory potency (when X=N), or conversion of the compounds into substrates for the enzymes (when X=S or O). However, the inclusion of a brominated methylene atom resulted in potent CE inhibition. Subsequent analysis with the alkyl diones [RC(O)C(O)R, where R ranged from CH₃ to C₈H₁₇] and 1-phenyl-2-alkyl-1,2-diones [PhC(O)C(O)R where R ranged from CH₃ to C₆H₁₃], demonstrated that the potency of enzyme inhibition directly correlated with the hydrophobicity (clogP) of the molecules. We conclude from these studies that that the inhibitory power of these 1,2-dione derivatives depends primarily upon the hydrophobicity of the R group, but also on the electrophilicity of the carbonyl group.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733699      PMCID: PMC3139784          DOI: 10.1016/j.bmc.2011.06.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  30 in total

1.  cDNA cloning, characterization and stable expression of novel human brain carboxylesterase.

Authors:  M Mori; M Hosokawa; Y Ogasawara; E Tsukada; K Chiba
Journal:  FEBS Lett       Date:  1999-09-10       Impact factor: 4.124

2.  Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.

Authors:  S M Guichard; C L Morton; E J Krull; C F Stewart; M K Danks; P M Potter
Journal:  Clin Cancer Res       Date:  1998-12       Impact factor: 12.531

3.  Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

Authors:  Christopher D Fleming; Sompop Bencharit; Carol C Edwards; Janice L Hyatt; Lyudmila Tsurkan; Feng Bai; Charles Fraga; Christopher L Morton; Escher L Howard-Williams; Philip M Potter; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2005-09-09       Impact factor: 5.469

4.  Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.

Authors:  Janice L Hyatt; Teri Moak; M Jason Hatfield; Lyudmila Tsurkan; Carol C Edwards; Monika Wierdl; Mary K Danks; Randy M Wadkins; Philip M Potter
Journal:  J Med Chem       Date:  2007-03-23       Impact factor: 7.446

5.  Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1.

Authors:  J Zhang; J C Burnell; N Dumaual; W F Bosron
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

6.  Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.

Authors:  M Jason Hatfield; Lyudmila Tsurkan; Michael Garrett; Timothy M Shaver; Janice L Hyatt; Carol C Edwards; Latorya D Hicks; Philip M Potter
Journal:  Biochem Pharmacol       Date:  2010-09-15       Impact factor: 5.858

7.  Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.

Authors:  Randy M Wadkins; Janice L Hyatt; Xin Wei; Kyoung Jin P Yoon; Monika Wierdl; Carol C Edwards; Christopher L Morton; John C Obenauer; Komath Damodaran; Paul Beroza; Mary K Danks; Philip M Potter
Journal:  J Med Chem       Date:  2005-04-21       Impact factor: 7.446

8.  Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.

Authors:  M K Danks; C L Morton; C A Pawlik; P M Potter
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

9.  Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.

Authors:  Janice L Hyatt; Vanessa Stacy; Randy M Wadkins; Kyoung Jin P Yoon; Monika Wierdl; Carol C Edwards; Matthias Zeller; Allen D Hunter; Mary K Danks; Guy Crundwell; Philip M Potter
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

10.  Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase.

Authors:  T Satoh; M Hosokawa; R Atsumi; W Suzuki; H Hakusui; E Nagai
Journal:  Biol Pharm Bull       Date:  1994-05       Impact factor: 2.233

View more
  6 in total

1.  Discovery of 4-Aryl-2-benzoyl-imidazoles as tubulin polymerization inhibitor with potent antiproliferative properties.

Authors:  Min Xiao; Sunjoo Ahn; Jin Wang; Jianjun Chen; Duane D Miller; James T Dalton; Wei Li
Journal:  J Med Chem       Date:  2013-04-09       Impact factor: 7.446

Review 2.  Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.

Authors:  Upendra A Argikar; Philip M Potter; J Matthew Hutzler; Punit H Marathe
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

Review 3.  Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review.

Authors:  Yanjiao Xu; Chengliang Zhang; Wenxi He; Dong Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-08       Impact factor: 2.441

4.  Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

Authors:  M Jason Hatfield; Lyudmila G Tsurkan; Janice L Hyatt; Carol C Edwards; Andrew Lemoff; Cynthia Jeffries; Bing Yan; Philip M Potter
Journal:  J Nat Prod       Date:  2013-01-03       Impact factor: 4.050

5.  Human carboxylesterase 2: Studies on the role of glycosylation for enzymatic activity.

Authors:  Márcia Alves; Joana Lamego; Tiago Bandeiras; Rute Castro; Hélio Tomás; Ana Sofia Coroadinha; Júlia Costa; Ana Luisa Simplício
Journal:  Biochem Biophys Rep       Date:  2015-11-19

6.  Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1.

Authors:  Victoria Arena de Souza; David J Scott; Joanne E Nettleship; Nahid Rahman; Michael H Charlton; Martin A Walsh; Raymond J Owens
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.